CanAssist Breast is a prognostic test for early-stage breast cancer patients. The test offers vital insights about the tumor & aids to personalize treatment.
New Publication Alert!
Can one tumor focus tell the full story?
Our latest study highlights how tiered testing can uncover hidden risk in Multifocal/Multicentric HR+/HER2- early breast cancer.
Read the full paper here: 10.5858/arpa.2025-0471-OA
At #IlluminateOncology Town Hall 3.0, Dr. Manjiri Bakre spoke about the science behind CanAssist® Breast- India’s first breast cancer prognostic test, helping 10,000+ patients avoid unnecessary treatment and receive care tailored to their tumor biology.
Not One-Size-Fits-All.
Every cancer is unique, and so is every patient.
On this World Cancer Day, we at OncoStem Diagnostics reaffirm our commitment to advancing personalized oncology by placing individual tumor biology at the heart of treatment decisions.
Dr. Manjiri Bakre joins the Round Table on Tech Entrepreneurship in Healthcare & Science at Celebrating Women Leaders in STEM, hosted by Apollo Proton Cancer Centre.
27th March 2025 | 2:45 PM | Taj Wellington Mews, Chennai
OncoStem Diagnostics is proud to announce that our Founder and CEO, Dr. Manjiri Bakre, will be a featured speaker at Technology & Innovation in Healthcare Summit '25 presented by Happiest Health on 23 January 2025 at Taj MG Road, Bangalore.
#HealthcareInnovation#CanAssistBreast